CTOs on the Move

Acadia Pharmaceuticals

www.acadia-pharm.com

 
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson`s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. Important Notice ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.acadia-pharm.com
  • 3611 Valley Centre Drive Suite 300
    San Diego, CA USA 92130
  • Phone: 858.558.2871

Executives

Name Title Contact Details
Nick Condos
Head of Information Security/Sr. Director Information Security Profile
Jerry Cipriani
Director, IT Data Services Profile
Nick C
Head of Information Security/Sr. Director Information Security Profile
Mark Schneyer
Executive Vice President and Chief Financial Officer Profile
Kim Alexander
Senior Director of Information Technology Profile

Similar Companies

The Futures HealthCore

The Futures HealthCore is a Springfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Plan of Nevada

Health Plan of Nevada offers you an extended network of providers to choose from, ranging from Primary Care to Specialties. For a complete listing, refer to the Provider Directory link to the right.

Southern Medical Products Inc

Southern Medical Products Inc is a Helena, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AURA

AURA Network Systems is a company that provides a nationwide network utilizing unique, licensed aviation spectrum to accelerate advanced levels of autonomy in the National Airspace System.

Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.